# Erasca, Inc.: filings

ERAS · Nasdaq · CIK 1761918 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eras.md) · [Financials](/companies/eras/financials.md) · [Filings](/companies/eras/filings.md) · [Insiders](/companies/eras/insiders.md)

## Reports and events: 92 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 108, 8-K 60, 144 43, 10-Q 16, 3 15, SCHEDULE 13G/A 12, SC 13G 11, CORRESP 8, SC 13G/A 8, 424B5 6, UPLOAD 6, 10-K 5, DEF 14A 5, DEFA14A 5, ARS 4, EFFECT 4, SCHEDULE 13G 4, S-3 3, S-8 3, SC 13D/A 3, 4/A 2, D 2, SEC STAFF LETTER 2, 144/A 1, 3/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 13:00 ET | [8-K](/filings/0001193125-26-423433.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-423433 |
| 2026-08-24 | 12:15 ET | [8-K](/filings/0001193125-26-361895.md) | 8.01 Other events | 0001193125-26-361895 |
| 2026-08-11 | 20:07 ET | [10-Q](/filings/0001193125-26-344611.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344611 |
| 2026-08-11 | 20:05 ET | [8-K](/filings/0001193125-26-344584.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344584 |
| 2026-08-10 | 21:14 ET | [8-K](/filings/0001193125-26-342669.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-342669 |
| 2026-07-14 | 21:03 ET | [8-K](/filings/0001193125-26-303357.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-303357 |
| 2026-07-13 | 20:19 ET | [8-K](/filings/0001193125-26-302045.md) | 8.01 Other events | 0001193125-26-302045 |
| 2026-07-01 | 21:41 ET | [8-K](/filings/0001193125-26-290881.md) | 5.07 Shareholder vote results | 0001193125-26-290881 |
| 2026-05-11 | 20:13 ET | [10-Q](/filings/0001193125-26-216788.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216788 |
| 2026-05-11 | 20:05 ET | [8-K](/filings/0001193125-26-216739.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216739 |
| 2026-04-28 | 20:40 ET | [DEF 14A](/filings/0001193125-26-187361.md) | Proxy statement, period 2026-06-26 | 0001193125-26-187361 |
| 2026-04-27 | 20:17 ET | [8-K](/filings/0001193125-26-182137.md) | 8.01 Other events | 0001193125-26-182137 |
| 2026-04-27 | 12:31 ET | [8-K](/filings/0001193125-26-179214.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-179214 |
| 2026-04-21 | 13:10 ET | [8-K](/filings/0001193125-26-165297.md) | 8.01 Other events | 0001193125-26-165297 |
| 2026-03-12 | 20:11 ET | [10-K](/filings/0001193125-26-104150.md) | Annual report, period 2025-12-31 | 0001193125-26-104150 |
| 2026-03-12 | 20:05 ET | [8-K](/filings/0001193125-26-104105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104105 |
| 2026-01-29 | 21:30 ET | [8-K](/filings/0001193125-26-029467.md) | 8.01 Other events | 0001193125-26-029467 |
| 2026-01-22 | 22:12 ET | [8-K](/filings/0001193125-26-019651.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-019651 |
| 2026-01-20 | 21:05 ET | [8-K](/filings/0001193125-26-016556.md) | 2.02 Results of operations | 0001193125-26-016556 |
| 2026-01-12 | 13:02 ET | [8-K](/filings/0001193125-26-009820.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009820 |
| 2025-11-12 | 21:16 ET | [10-Q](/filings/0001193125-25-277625.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277625 |
| 2025-11-12 | 21:09 ET | [8-K](/filings/0001193125-25-277571.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277571 |
| 2025-08-12 | 20:27 ET | [10-Q](/filings/0001193125-25-178996.md) | Quarterly report, period 2025-06-30 | 0001193125-25-178996 |
| 2025-08-12 | 20:08 ET | [8-K](/filings/0001193125-25-178950.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178950 |
| 2025-06-26 | 21:04 ET | [8-K](/filings/0000950170-25-090493.md) | 5.07 Shareholder vote results | 0000950170-25-090493 |
| 2025-05-13 | 20:24 ET | [10-Q](/filings/0000950170-25-070418.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070418 |
| 2025-05-13 | 20:10 ET | [8-K](/filings/0000950170-25-070336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070336 |
| 2025-04-29 | 20:25 ET | [DEF 14A](/filings/0001193125-25-103868.md) | Proxy statement, period 2025-06-24 | 0001193125-25-103868 |
| 2025-03-20 | 20:19 ET | [10-K](/filings/0000950170-25-042682.md) | Annual report, period 2024-12-31 | 0000950170-25-042682 |
| 2025-03-20 | 20:10 ET | [8-K](/filings/0000950170-25-042659.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042659 |
| 2025-01-13 | 14:10 ET | [8-K](/filings/0000950170-25-004613.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004613 |
| 2024-11-12 | 21:21 ET | [10-Q](/filings/0000950170-24-125481.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125481 |
| 2024-11-12 | 21:05 ET | [8-K](/filings/0000950170-24-125337.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125337 |
| 2024-10-24 | 12:10 ET | [8-K](/filings/0000950170-24-116856.md) | 8.01 Other events | 0000950170-24-116856 |
| 2024-08-12 | 20:12 ET | [10-Q](/filings/0000950170-24-095437.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095437 |
| 2024-08-12 | 20:05 ET | [8-K](/filings/0000950170-24-095408.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095408 |
| 2024-06-24 | 13:18 ET | [8-K](/filings/0000950170-24-076476.md) | 5.07 Shareholder vote results | 0000950170-24-076476 |
| 2024-06-24 | 13:15 ET | [8-K](/filings/0000950170-24-076474.md) | 8.01 Other events | 0000950170-24-076474 |
| 2024-05-17 | 10:05 ET | [8-K](/filings/0001193125-24-141066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-141066 |
| 2024-05-16 | 20:21 ET | [8-K](/filings/0001193125-24-140591.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-140591 |
| 2024-05-08 | 20:12 ET | [10-Q](/filings/0000950170-24-055668.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055668 |
| 2024-05-08 | 20:08 ET | [8-K](/filings/0000950170-24-055644.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055644 |
| 2024-04-26 | 20:06 ET | [DEF 14A](/filings/0001193125-24-117977.md) | Proxy statement, period 2024-06-20 | 0001193125-24-117977 |
| 2024-03-28 | 20:14 ET | [8-K](/filings/0001193125-24-080630.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-080630 |
| 2024-03-27 | 20:15 ET | [10-K](/filings/0000950170-24-037193.md) | Annual report, period 2023-12-31 | 0000950170-24-037193 |
| 2024-03-27 | 20:05 ET | [8-K](/filings/0000950170-24-037161.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-037161 |
| 2024-01-30 | 21:41 ET | [SC 13D/A](/filings/0000929638-24-000306.md) | Ownership report, active investor, amended | 0000929638-24-000306 |
| 2024-01-09 | 14:00 ET | [8-K](/filings/0000950170-24-003199.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003199 |
| 2023-12-11 | 14:19 ET | [8-K](/filings/0000950170-23-069212.md) | 8.01 Other events | 0000950170-23-069212 |
| 2023-11-28 | 14:21 ET | [8-K](/filings/0000950170-23-066250.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-066250 |

Page 1 of 2. [Older](/companies/eras/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.